Fasting plasma glucose correlates with angiographic coronary artery disease prevalence and severity in Chinese patients without known diabetes

Acta Diabetologica

Volumn 50, Issue 3, 2013, Pages 333-340

  Gui, Ming Hui ^a   Li, Xiang ^a   Lu, Zhi Qiang ^a   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Coronary angiography; Coronary artery disease; Fasting plasma glucose

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENSINI SCORE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; WAIST HIP RATIO;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84879217119     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-012-0405-2     Document Type: Article

References (33)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241(19):2035-2038
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16(2):434-444
3. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC (2000) Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23(8):1113-1118
4. Davidson MB (2002) Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care 25(10):1883-1885
5. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160-3167
6. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342(6):381-389
7. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977-986
8. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, InterASIA Collaborative Group (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46(9):1190-1198
9. Farhan S, Jarai R, Tentzeris I, Kautzky-Willer A, Samaha E, Smetana P, Jakl-Kotauschek G, Wojta J, Huber K (2012) Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease. Clin Res Cardiol [Epub ahead of print]
10. Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M (2011) A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovasc Diabetol 10:56
11. Berry C, Noble S, Grégoire JC, Ibrahim R, Levesquie S, Lavoie MA, L'Allier PL, Tardif JC (2010) Glycaemic status influences the nature and severity of coronary artery disease. Diabetologia 53(4):652-658
12. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539-553
13. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959-969
14. Joint European Society of Cardiology/American College of Cardiology Committee (2000) Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21(18):1502-1513
15. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
16. Fievet C, Nuttens MC, Ducimetiere P, Fruchart JC, Bertrand M, Salomez JL (1991) Relation of arteriographically defined coronary artery disease to serum lipoprotein particles mapped with monoclonal antibodies. Circulation 84(1):153-159
17. Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606
18. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C (2011) Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 10:19
19. Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, Lanas F, Avezum A, Budaj A, Jung H, Desai D, Bosch J, Yusuf S, Gerstein HC (2011) Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Cardiovasc Prev Rehabil [Epub ahead of print]
20. DECODE Study Group, The European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161(3):397-405
21. Kim HK, Lee SK, Suh CJ, Yoon HJ, Lee KY, Park HY, Kang MH (2003) Postchallenge hyperglycemia but not hyperinsulinemia is associated with angiographically documented coronary atherosclerosis in Korean subjects. Diabetes Res Clin Pract 59(2):129-136
22. Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G (2008) High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Chin Med J (Engl) 121(24):2509-2516
23. Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC, Drexel H (2010) Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients]. Eur Heart J 31(13):1583-1590
24. Ning F, Tuomilehto J, Pyörälä K, Onat A, Söderberg S, DECODE Study Group (2010) Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 33(10):2211-2216
25. Chu CS, Lee KT, Cheng KH, Lee MY, Kuo HF, Lin TH, Su HM, Voon WC, Sheu SH, Lai WT (2012) Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol 11(1):21
26. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology, ESC Committee for Practice Guidelines (CPG) (2006) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27(11):1341-1381
27. Dong X, Zhou L, Zhai Y, Lu B, Wang D, Shi H, Luo X, Fan W, Hu R (2008) Impaired fasting glucose and the prevalence and severity of angiographic coronary artery disease in high-risk Chinese patients. Metabolism 57(1):24-29
28. Yan Q, Gu WQ, Hong J, Zhang YF, Su YX, Gui MH, Zhang Y, Chi ZN, Zhang YW, Li XY, Ning G (2009) Coronary angiographic studies of impaired glucose regulation and coronary artery disease in Chinese nondiabetic subjects. Endocrine 36(3):457-463
29. Konstantinou DM, Chatzizisis YS, Louridas GE, Parcharidis GE, Giannoglou GD (2010) Non-diabetic hyperglycaemia correlates with angiographic coronary artery disease prevalence and severity. Diabetes Metab 36(5):402-408
30. Onat A, Can G, Ciçek G, Ayhan E, Doǧan Y, Kaya H (2011) Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults. Acta Diabetol [Epub ahead of print]
31. Nakagami T, DECODA Study Group (2004) Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47(3):385-394
32. American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27(Suppl 1):S11-S14
33. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ (1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39(3):298-305